The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
120916506 12091650 6 F 20151005 20160912 20160218 20160916 PER US-GILEAD-2016-0198792 GILEAD 5.00 YR C M Y 0.00000 20160916 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
120916506 12091650 1 PS AMBRISENTAN AMBRISENTAN 1 Unknown UNK U 22081 TABLET
120916506 12091650 2 SS FLOLAN EPOPROSTENOL SODIUM 1 Unknown CONCENTRATION: 45,000 NG/MLPUMP RATE: 74 ML/DAYVIAL STRENGTH: 1.5 MG140 NG/KG/ MIN45000 NG/MLVI[...] U P061 0 134 DF
120916506 12091650 3 SS FLOLAN EPOPROSTENOL SODIUM 1 Intravenous (not otherwise specified) 162NG/KG/MIN, 1.5MG VIAL STR, 60,000NG/ML CONC, 80 ML/DAY RATE U T366 0
120916506 12091650 4 SS FLOLAN EPOPROSTENOL SODIUM 1 Intravenous (not otherwise specified) 174 DF (CONCENTRATION 60,000 NG/ML, PUMP RATE 86 ML/DAY, VIAL STRENGTH 1.5 MG), UNK U V378 0 174 DF
120916506 12091650 5 SS FLOLAN EPOPROSTENOL SODIUM 1 Intravenous (not otherwise specified) 180 NG/KG/MIN , CO U V785 0 180 DF
120916506 12091650 6 SS FLOLAN EPOPROSTENOL SODIUM 1 Intravenous (not otherwise specified) 190 NG/KG/MIN, 1.5 MG VIAL STRENGTH, 60,000 NG/ML CONCENTRATION, 93 ML/DAY RATE U Z880 0 190 DF
120916506 12091650 7 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U P193 0
120916506 12091650 8 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK U S553 0
120916506 12091650 9 SS FLOLAN EPOPROSTENOL SODIUM 1 Unknown UNK UNK, CO U C769109 0
120916506 12091650 10 C TRACLEER BOSENTAN 1 U 0
120916506 12091650 11 C SILDENAFIL. SILDENAFIL 1 U 0
120916506 12091650 12 C REVATIO SILDENAFIL CITRATE 1 UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
120916506 12091650 1 Product used for unknown indication
120916506 12091650 2 Pulmonary arterial hypertension
120916506 12091650 9 Pulmonary arterial hypertension

Outcome of event

Event ID CASEID OUTC COD
120916506 12091650 HO
120916506 12091650 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
120916506 12091650 Catheter site erythema
120916506 12091650 Catheterisation cardiac
120916506 12091650 Central venous catheterisation
120916506 12091650 Cerebrovascular accident
120916506 12091650 Colonoscopy
120916506 12091650 Device issue
120916506 12091650 Device related infection
120916506 12091650 Haemoglobin decreased
120916506 12091650 Haemorrhage
120916506 12091650 Headache
120916506 12091650 Infusion site infection
120916506 12091650 Malaise
120916506 12091650 Off label use
120916506 12091650 Sinus congestion
120916506 12091650 Sinusitis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
120916506 12091650 2 20080718 0
120916506 12091650 6 20121003 0